Cargando…
Dietary α-Eleostearic Acid Ameliorates Experimental Inflammatory Bowel Disease in Mice by Activating Peroxisome Proliferator-Activated Receptor-γ
BACKGROUND: Treatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options are needed. Peroxisome proliferator-activated receptor-gamma (PPARγ) has been identified as a pot...
Autores principales: | Lewis, Stephanie N., Brannan, Lera, Guri, Amir J., Lu, Pinyi, Hontecillas, Raquel, Bassaganya-Riera, Josep, Bevan, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164124/ https://www.ncbi.nlm.nih.gov/pubmed/21904603 http://dx.doi.org/10.1371/journal.pone.0024031 |
Ejemplares similares
-
The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease
por: Guri, Amir J, et al.
Publicado: (2010) -
Immunoregulatory mechanisms of macrophage PPAR γ in mice with experimental inflammatory bowel disease
por: Hontecillas, Raquel, et al.
Publicado: (2010) -
The Role of Peroxisome Proliferator-Activated Receptor γ in Immune Responses to Enteroaggregative Escherichia coli Infection
por: Philipson, Casandra W., et al.
Publicado: (2013) -
Immunoregulatory Actions of Epithelial Cell PPAR γ at the Colonic Mucosa of Mice with Experimental Inflammatory Bowel Disease
por: Mohapatra, Saroj K., et al.
Publicado: (2010) -
Treatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists
por: Bassaganya-Riera, Josep, et al.
Publicado: (2011)